Long-term safety of eplontersen treated aTTR patients and in liver transplant and severely hepatic impaired subpopulations

Trial Identifier:	D8450R00022
Sponsor:	AstraZeneca
Collaborator:	ICON CLINICAL RESEARCH LIMITED
Start Date:	September 2026
Primary Completion Date:	January 2032
Study Completion Date:	January 2032

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.